https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medolife-rx-dba-medolife-corp-aelia-inc-and-quanta-inc-651522-04192023
Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc. - 651522 - 04/19/2023 | FDA
Unapproved New Drugs/Misbranded